IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
88.80
-1.34 (-1.49%)
Apr 23, 2026, 4:00 PM EDT - Market closed

IRADIMED CORPORATION Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,1351,243699601356580
Market Cap Growth
80.83%77.87%16.32%68.72%-38.55%106.56%
Enterprise Value
1,0841,192646.81552.84300.15519.36
Last Close Price
88.8097.2855.0047.4728.2946.21
PE Ratio
50.7455.5936.6735.1627.7462.45
Forward PE
46.4154.0434.5933.9126.0765.08
PEG Ratio
-0.770.770.770.770.77
PS Ratio
13.5414.849.549.176.6813.86
PB Ratio
12.0013.148.058.414.838.03
P/TBV Ratio
12.0613.228.108.464.858.06
P/FCF Ratio
66.0672.3739.6899.7638.6353.79
P/OCF Ratio
45.5049.8427.2844.6335.4751.49
EV/Sales Ratio
12.9314.238.838.435.6312.42
EV/EBITDA Ratio
39.6943.6528.3926.5818.4246.27
EV/EBIT Ratio
41.4645.6029.4527.5919.2152.90
EV/FCF Ratio
63.0969.3936.7191.7632.5648.20
Debt / Equity Ratio
-00.000.020.030.03
Debt / EBITDA Ratio
--00.100.140.22
Debt / FCF Ratio
--00.340.240.23
Net Debt / Equity Ratio
-0.54-0.54-0.60-0.67-0.76-0.83
Net Debt / EBITDA Ratio
-1.87-1.87-2.29-2.29-3.42-5.35
Net Debt / FCF Ratio
-2.98-2.98-2.96-7.92-6.05-5.57
Asset Turnover
0.810.810.770.740.630.54
Inventory Turnover
1.771.771.451.692.492.37
Quick Ratio
6.376.377.383.808.339.91
Current Ratio
7.987.988.844.659.0611.18
Return on Equity (ROE)
24.78%24.78%24.31%23.70%17.59%13.96%
Return on Assets (ROA)
20.01%20.01%18.27%17.84%14.72%12.09%
Return on Invested Capital (ROIC)
44.69%44.69%44.71%52.64%63.22%56.32%
Return on Capital Employed (ROCE)
27.76%27.76%26.52%26.23%20.43%13.81%
Earnings Yield
1.98%1.80%2.73%2.84%3.61%1.60%
FCF Yield
1.51%1.38%2.52%1.00%2.59%1.86%
Dividend Yield
0.90%1.22%1.96%2.21%3.53%0.00%
Payout Ratio
69.14%66.90%71.11%76.91%97.90%0.00%
Buyback Yield / Dilution
-0.55%-0.55%-0.48%-0.68%-0.36%-1.21%
Total Shareholder Return
0.35%0.67%1.48%1.53%3.18%-1.21%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q